News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,513 Results
Type
Article (68848)
Company Profile (296)
Press Release (630369)
Section
Business (196774)
Career Advice (2829)
Deals (34903)
Drug Delivery (109)
Drug Development (83693)
Employer Resources (172)
FDA (16753)
Job Trends (14936)
News (342309)
Policy (34675)
Tag
Academia (2864)
Alliances (50533)
Alzheimer's disease (1319)
Approvals (16650)
Artificial intelligence (132)
Bankruptcy (329)
Best Places to Work (11085)
Biotechnology (164)
Breast cancer (114)
Cancer (974)
Cardiovascular disease (87)
Career advice (2368)
Cell therapy (221)
Clinical research (65680)
Collaboration (343)
Compensation (172)
COVID-19 (2722)
Data (873)
Diabetes (146)
Diagnostics (6092)
Drug pricing (98)
Earnings (74807)
Employer resources (153)
Events (103006)
Executive appointments (258)
FDA (17206)
Funding (293)
Gene therapy (169)
GLP-1 (663)
Government (4383)
Healthcare (18313)
Infectious disease (2804)
Inflammatory bowel disease (109)
Interviews (519)
IPO (16025)
Job creations (4165)
Job search strategy (1991)
Layoffs (468)
Legal (8391)
Lung cancer (172)
Manufacturing (170)
Medical device (12622)
Medtech (12627)
Mergers & acquisitions (18911)
Metabolic disorders (427)
Neuroscience (1584)
NextGen Class of 2024 (6310)
Non-profit (4619)
Northern California (1217)
Obesity (253)
Opinion (228)
Patents (100)
People (56703)
Pharmaceutical (98)
Phase I (20230)
Phase II (28519)
Phase III (21898)
Pipeline (216)
Postmarket research (2998)
Preclinical (8987)
Radiopharmaceuticals (243)
Rare diseases (200)
Real estate (6204)
Regulatory (23211)
Research institute (2615)
Resumes & cover letters (468)
Southern California (1069)
Startups (3632)
United States (11731)
Vaccines (633)
Weight loss (212)
Date
Today (236)
Last 7 days (864)
Last 30 days (3093)
Last 365 days (36419)
2024 (31156)
2023 (40501)
2022 (51598)
2021 (55859)
2020 (53817)
2019 (45868)
2018 (34707)
2017 (33986)
2016 (33810)
2015 (38729)
2014 (32400)
2013 (28455)
2012 (29866)
2011 (30330)
2010 (28897)
Location
Africa (963)
Arizona (171)
Asia (43000)
Australia (7399)
California (2713)
Canada (1137)
China (209)
Colorado (121)
Connecticut (137)
Europe (97909)
Florida (392)
Georgia (99)
Illinois (313)
Indiana (176)
Kansas (92)
Maryland (530)
Massachusetts (2265)
Michigan (144)
Minnesota (252)
New Jersey (835)
New York (844)
North Carolina (720)
Northern California (1217)
Ohio (123)
Pennsylvania (720)
South America (1329)
Southern California (1069)
Texas (375)
Washington State (328)
699,513 Results for "apr applied pharma research s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tempus Announces Collaboration With JW Pharmaceutical to Apply Real-World Data and Biological Modeling to Enhance Early Research and Development
October 28, 2024
·
5 min read
Derm-Biome Pharmaceuticals and TransBIOtech awarded $450,000 Applied Research and Development (ARD) grant funding
Derm-Biome Pharmaceuticals, Inc is pleased to announce that, in partnership with TransBIOtech, is being awarded an Applied Research and Development grant via the College and Community Innovation program administered through the Natural Sciences and Engineering Council of Canada in collaboration with the Social Sciences and Humanities Research Council and the Canadian Institutes of Health Research.
May 8, 2024
·
1 min read
Pharm Country
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced seven presentations will be shared at the American Academy of Neurology (AAN) 2024 Annual Meeting being held in Denver, Colo., Apr.13-18, 2024.
April 12, 2024
·
9 min read
Podcast
BMS’ Schizophrenia Approval, Pfizer’s Sudden Sickle Cell Withdrawal and Roche’s Pharma Day
Bristol Myers Squibb wins approval for the first novel schizophrenia drug in decades; Pfizer pulls Oxbryta from the market; new IVF and abortion laws could derail women’s health research; Roche touts CDK inhibitor deal and obesity pipeline and
BioSpace
heads to Meeting on the Mesa.
October 2, 2024
·
1 min read
·
Heather McKenzie
Cell and gene therapy
Big Pharma’s Interest Grows in Evolving Cell and Gene Therapy Sector
Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand their presence in the industry.
October 9, 2024
·
4 min read
·
Greg Slabodkin
Press Releases
Mitsubishi Tanabe Pharma America to Showcase ALS Research at 2024 AANEM Annual Meeting
October 16, 2024
·
7 min read
Drug Development
Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051
Aprea Therapeutics, Inc. today announced that the first patient has been dosed in the ACESOT-1051 Phase 1 study evaluating daily oral WEE1 inhibitor APR-1051 as monotherapy in advanced solid tumor patients with unmet medical need.
June 17, 2024
·
7 min read
Biotech Beach
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
The Bruker Applied Mass Spectrometry Division is showcasing some of its latest innovations at ASMS 2024.
June 3, 2024
·
4 min read
Biotech Beach
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
Applied BioCode now offers STI + Resistance Panel on the BioCode® MDx-3000 system for research use only (RUO).
April 15, 2024
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America Unveils New ALS Research Findings at NEALS 2024 Annual Meeting
October 18, 2024
·
10 min read
1 of 69,952
Next